Fennec Pharmaceuticals (FENC) Revenue (2020 - 2025)

Fennec Pharmaceuticals has reported Revenue for 4 years, with the latest figure at $13.8 million in Q4 2025.

• For the quarter ending Q4 2025, Revenue rose 73.84% year-over-year to $13.8 million; the trailing twelve-month figure through Dec 2025 stood at $44.6 million (down 6.09% YoY), and the FY2025 full-year result was $44.6 million, down 6.09% from the prior year.
• Revenue for Q4 2025 stood at $13.8 million, up from $12.5 million in the prior quarter.
• The five-year high for Revenue was $25.4 million in Q1 2024, with the low at $1.7 million in Q1 2023.
• Historically, Revenue has averaged $9.5 million across 3 years, with a median of $8.3 million in 2024.
• Annual changes were most pronounced in 2024 — Revenue jumped 1413.24% — and 2025, when it plunged 65.52%.
• Fennec Pharmaceuticals' Revenue stood at $9.7 million in 2023, then decreased by 18.59% to $7.9 million in 2024, then jumped by 73.84% to $13.8 million in 2025.
• The last three Revenue figures came in at $13.8 million (Q4 2025), $12.5 million (Q3 2025), and $9.7 million (Q2 2025), per Business Quant data.